Education
About Us
Working with TipRanks
Follow Us
RICHARD II JACINTO Insider Profile
4 Followers
RICHARD II JACINTO, Ten Percent Owner at Diamedica Therapeutics, holds 4.96M shares in Diamedica Therapeutics (Ticker: DMAC). Most recently, RICHARD II JACINTO Bought $400,000 shares of Diamedica Therapeutics on Jul 25, 2025 for an estimated value of 1.40M.
RICHARD II JACINTO has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of RICHARD II JACINTO's holdings
Insider Roles
Ten Percent Owner
Roles that RICHARD II JACINTO holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by RICHARD II JACINTO
RICHARD II JACINTO's Trading History
List of latest transactions for each holding click on a transaction to see RICHARD II JACINTO's performance on stock
You May Also Like
RICHARD II JACINTO insider profile FAQ
What is the percentage of profitable transactions made by RICHARD II JACINTO?
The percentage of profitable transactions made by RICHARD II JACINTO is ―.
What is the average return per transaction made by RICHARD II JACINTO?
The average return per transaction made by RICHARD II JACINTO is ―.
What stocks does RICHARD II JACINTO hold?
RICHARD II JACINTO holds: DMAC stocks.
What was RICHARD II JACINTO’s latest transaction?
RICHARD II JACINTO latest transaction was an Informative Buy of $1.40M.
What was RICHARD II JACINTO's most profitable transaction?
RICHARD II JACINTO’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is RICHARD II JACINTO's role in Diamedica Therapeutics?
RICHARD II JACINTO's role in Diamedica Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.